glp-1 and muscle mass loss Weight with medicines does not result in a disproportionate loss of or function in obese mice humans Study finds GLP-1 receptor agonists

The FDA's adverse event reporting system has received reports related to compounded GLP-1 medications involving dosing errors and other adverse events

Some of the highest risks, when compared to placebo groups, stemmed from popular versions of GLP-1 receptor agonists, including

Severe diarrhea can lead to dehydration

The how much protein on semaglutide guide provides detailed recommendations

Mild or inconsistent dehydration may come with the territory, but persistent or severe lack of fluids is worth seeing a doctor about

Individual experiences vary and may depend on the specific medication used, pre-existing mental health conditions, and each patients unique health profile and circumstances